More than 67,000 Americans are expected to be diagnosed with pancreatic cancer this year, but a new blood test is offering ...
SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...
The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...
"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
Oncodetect uses whole exome sequencing to analyze circulating tumor DNA, providing quantitative insights into disease status for informed treatment decisions. The test offers a "Detected" or "Not ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
MARAbio Systems has commercially introduced a new blood test for identifying maternal autoantibody related autism.